Cancer

Cologuard Exact Sciences
MedTech

Abbott inks $23B deal for Exact Sciences in cancer testing buy

Abbott has signed up to buy Exact Sciences in the largest diagnostics deal to date, acquiring the maker of the Cologuard at-home screening test.
Conor Hale Nov 20, 2025 10:30am
blood test money

Grail sees Q3 sales jump, eyes Q1 for FDA Galleri PMA submission

Nov 13, 2025 9:05am
weight loss from cancer

ESMO: Pfizer sees year-long weight gain in cancer patients

Oct 17, 2025 12:45pm
antibody antibody-drug conjugate antibody drug conjugate ADC

Boehringer digs in on ADCs with $991M AimedBio licensing accord

Oct 15, 2025 10:05am
Graphic images of different entities adding money to a pile

Tubulis touts $361M series C as next-gen ADC data drop nears

Oct 15, 2025 5:01am
blood test tube

Exact Sciences rolls out Cancerguard multi-cancer blood test

Sep 11, 2025 1:00pm